JP2025084754A5 - - Google Patents
Info
- Publication number
- JP2025084754A5 JP2025084754A5 JP2025016270A JP2025016270A JP2025084754A5 JP 2025084754 A5 JP2025084754 A5 JP 2025084754A5 JP 2025016270 A JP2025016270 A JP 2025016270A JP 2025016270 A JP2025016270 A JP 2025016270A JP 2025084754 A5 JP2025084754 A5 JP 2025084754A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- hypnotic
- nri
- muscle relaxant
- release formulation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962803223P | 2019-02-08 | 2019-02-08 | |
| US62/803,223 | 2019-02-08 | ||
| PCT/US2020/017323 WO2020163785A1 (en) | 2019-02-08 | 2020-02-07 | Methods and compositions for treating sleep apnea |
| JP2021546285A JP7705348B2 (ja) | 2019-02-08 | 2020-02-07 | 睡眠時無呼吸を治療するための方法および組成物 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021546285A Division JP7705348B2 (ja) | 2019-02-08 | 2020-02-07 | 睡眠時無呼吸を治療するための方法および組成物 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025084754A JP2025084754A (ja) | 2025-06-03 |
| JP2025084754A5 true JP2025084754A5 (https=) | 2025-10-24 |
Family
ID=71947080
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021546285A Active JP7705348B2 (ja) | 2019-02-08 | 2020-02-07 | 睡眠時無呼吸を治療するための方法および組成物 |
| JP2025016270A Pending JP2025084754A (ja) | 2019-02-08 | 2025-02-03 | 睡眠時無呼吸を治療するための方法および組成物 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021546285A Active JP7705348B2 (ja) | 2019-02-08 | 2020-02-07 | 睡眠時無呼吸を治療するための方法および組成物 |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US12558327B2 (https=) |
| EP (2) | EP3920898B1 (https=) |
| JP (2) | JP7705348B2 (https=) |
| KR (1) | KR20210125507A (https=) |
| CN (2) | CN118557736A (https=) |
| AU (2) | AU2020219809B2 (https=) |
| BR (1) | BR112021015600A2 (https=) |
| CA (1) | CA3129270A1 (https=) |
| EA (1) | EA202192202A1 (https=) |
| ES (1) | ES3049086T3 (https=) |
| IL (1) | IL285197A (https=) |
| MX (2) | MX2021009407A (https=) |
| MY (1) | MY210043A (https=) |
| PH (1) | PH12021551850A1 (https=) |
| SG (1) | SG11202108225QA (https=) |
| UA (1) | UA130366C2 (https=) |
| WO (1) | WO2020163785A1 (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102874891B1 (ko) | 2018-01-30 | 2025-10-21 | 애프니메드, 인코포레이티드 (델라웨어) | 수면 무호흡증을 치료하기 위한 방법 및 조성물 |
| CN118557736A (zh) | 2019-02-08 | 2024-08-30 | 布里格姆妇女医院 | 用于治疗睡眠呼吸暂停的方法和组合物 |
| WO2022204228A1 (en) * | 2021-03-24 | 2022-09-29 | Apnimed, Inc. (Delaware) | Methods and compositions for treating sleep apnea |
| US20240277719A1 (en) * | 2021-06-17 | 2024-08-22 | Apnimed, Inc. (Delaware) | Norepinephrine reuptake inhibitors for treating sleep apnea |
| EP4522149A1 (en) * | 2022-05-13 | 2025-03-19 | Apnimed, Inc. (Delaware) | Methods and compositions for treating sleep apnea |
| KR20250057804A (ko) * | 2022-09-02 | 2025-04-29 | 애프니메드, 인코포레이티드 (델라웨어) | 수면 무호흡증을 치료하기 위한 방법 및 조성물 |
Family Cites Families (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4522811A (en) | 1982-07-08 | 1985-06-11 | Syntex (U.S.A.) Inc. | Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides |
| AU767877B2 (en) | 1999-05-20 | 2003-11-27 | Sepracor, Inc. | Methods for treatment of asthma using S-oxybutynin |
| PT1257277E (pt) | 2000-02-24 | 2005-09-30 | Pharmacia & Upjohn Co Llc | Novas combinacoes de farmacos |
| US20020155113A1 (en) | 2001-03-13 | 2002-10-24 | Miyoung Chun | Methods for treating or preventing cardiovascular disorders by modulating metalloprotease function |
| US20030185882A1 (en) | 2001-11-06 | 2003-10-02 | Vergez Juan A. | Pharmaceutical compositions containing oxybutynin |
| US20040235925A1 (en) | 2002-12-17 | 2004-11-25 | Pharmacia Corporation | Method for the treatment, prevention, or inhibition of a CNS disorder and/or pain and inflammation using a combination of duloxetine, venlafaxine or atomoxetine and a cyclooxygenase-2 selective inhibitor and compositions thereof |
| US20070219201A1 (en) | 2004-05-27 | 2007-09-20 | Warner-Lambert Company Llc | Combination of atomoxetine and a 5ht1a receptor agonist for treating adhd and other disorders |
| US20060039866A1 (en) | 2004-08-20 | 2006-02-23 | Cypress Bioscience, Inc. | Method for treating sleep-related breathing disorders |
| US8252321B2 (en) | 2004-09-13 | 2012-08-28 | Chrono Therapeutics, Inc. | Biosynchronous transdermal drug delivery for longevity, anti-aging, fatigue management, obesity, weight loss, weight management, delivery of nutraceuticals, and the treatment of hyperglycemia, alzheimer's disease, sleep disorders, parkinson's disease, aids, epilepsy, attention deficit disorder, nicotine addiction, cancer, headache and pain control, asthma, angina, hypertension, depression, cold, flu and the like |
| EP1827450A4 (en) * | 2004-11-17 | 2009-04-22 | Cypress Bioscience Inc | METHOD FOR REDUCING THE SIDE EFFECTS OF TREATMENT WITH MIRTAZAPINE |
| CN101132777A (zh) | 2004-12-20 | 2008-02-27 | 科利吉姆制药公司 | 用于睡眠障碍的药物组合物 |
| FR2889811B1 (fr) | 2005-08-19 | 2009-10-09 | Sanofi Aventis Sa | Association d'un agent hypnotique a duree d'action longue et d'un agent hypnotique a duree d'action courte, composition pharmaceutique la contenant et son application en therapeutique. |
| PL2083811T3 (pl) | 2006-11-22 | 2017-05-31 | Clinical Research Associates, Llc | Sposoby leczenia zespołu downa, zespołu łamliwego chromosomu x oraz autyzmu |
| WO2008122019A1 (en) | 2007-04-02 | 2008-10-09 | Cypress Biosciences, Inc. | Improving the tolerability of both mirtazapine and reboxetine by using them in combination |
| EP2142183A2 (en) * | 2007-04-09 | 2010-01-13 | Sepracor Inc. | Methods and compositions comprising desvenlafaxine or duloxetine for treating sleep-related breathing disorders |
| EP2167096A4 (en) * | 2007-06-13 | 2010-07-14 | Cypress Bioscience Inc | IMPROVING TOLERANCE TO MIRTAZAPINE AND A SECOND ACTIVE INGREDIENT BY THE COMBINED USE OF THEM |
| AR069875A1 (es) | 2007-12-21 | 2010-02-24 | Eurand Inc | Composiciones de temazepam para tabletas de desintegracion oral y metodo de preparacion |
| US20100204058A1 (en) | 2009-01-28 | 2010-08-12 | Howard Yuan-Hao Chang | Profiling for Determination of Response to Treatment for Inflammatory Disease |
| JP2014503593A (ja) | 2011-01-28 | 2014-02-13 | ファンタスティック・メディカル・リサーチ・インスティテュート・エルエルシー | 閉塞性睡眠時無呼吸を処置するための方法 |
| US20170304286A1 (en) | 2014-10-24 | 2017-10-26 | Launx Biomedical Co., Ltd. | New indication of paroxetine pharmaceutical composition for treating cancer |
| MX373319B (es) * | 2015-04-27 | 2020-06-13 | Arena Pharm Inc | Derivados de hexahidro-[1-4]diazepino[6,7,1-hi]indol-8-carboxamida como agonistas del receptor 5-ht2c y el uso de los mismos en el tratamiento de enfermedades relacionadas con dicho receptor. |
| US10022355B2 (en) | 2015-06-12 | 2018-07-17 | Axovant Sciences Gmbh | Diaryl and arylheteroaryl urea derivatives as modulators of the 5-HT2A serotonin receptor useful for the prophylaxis and treatment of REM sleep behavior disorder |
| ES2925951T3 (es) * | 2015-07-22 | 2022-10-20 | John Hsu | Composición que comprende un agente terapéutico y un estimulante respiratorio y métodos para su uso |
| GEAP202416602A (en) | 2017-04-28 | 2024-10-10 | Brigham & Womens Hospital Inc | Methods and compositions for treating sleep apnea |
| KR102874891B1 (ko) | 2018-01-30 | 2025-10-21 | 애프니메드, 인코포레이티드 (델라웨어) | 수면 무호흡증을 치료하기 위한 방법 및 조성물 |
| CN118557736A (zh) | 2019-02-08 | 2024-08-30 | 布里格姆妇女医院 | 用于治疗睡眠呼吸暂停的方法和组合物 |
-
2020
- 2020-02-07 CN CN202410525932.1A patent/CN118557736A/zh active Pending
- 2020-02-07 PH PH1/2021/551850A patent/PH12021551850A1/en unknown
- 2020-02-07 AU AU2020219809A patent/AU2020219809B2/en active Active
- 2020-02-07 UA UAA202104441A patent/UA130366C2/uk unknown
- 2020-02-07 EP EP20752195.6A patent/EP3920898B1/en active Active
- 2020-02-07 KR KR1020217027063A patent/KR20210125507A/ko active Pending
- 2020-02-07 SG SG11202108225QA patent/SG11202108225QA/en unknown
- 2020-02-07 BR BR112021015600-3A patent/BR112021015600A2/pt unknown
- 2020-02-07 MX MX2021009407A patent/MX2021009407A/es unknown
- 2020-02-07 ES ES20752195T patent/ES3049086T3/es active Active
- 2020-02-07 US US17/428,596 patent/US12558327B2/en active Active
- 2020-02-07 JP JP2021546285A patent/JP7705348B2/ja active Active
- 2020-02-07 EA EA202192202A patent/EA202192202A1/ru unknown
- 2020-02-07 WO PCT/US2020/017323 patent/WO2020163785A1/en not_active Ceased
- 2020-02-07 CA CA3129270A patent/CA3129270A1/en active Pending
- 2020-02-07 CN CN202080026282.6A patent/CN113692277B/zh active Active
- 2020-02-07 EP EP25200289.4A patent/EP4635514A3/en active Pending
- 2020-02-07 MY MYPI2021004502A patent/MY210043A/en unknown
-
2021
- 2021-07-28 IL IL285197A patent/IL285197A/en unknown
- 2021-08-04 MX MX2025004365A patent/MX2025004365A/es unknown
-
2025
- 2025-02-03 JP JP2025016270A patent/JP2025084754A/ja active Pending
- 2025-07-15 AU AU2025205464A patent/AU2025205464A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2025084754A5 (https=) | ||
| JP2022519721A5 (https=) | ||
| JP2023139000A5 (https=) | ||
| TWI455723B (zh) | 納曲酮及安非他酮於治療超重或肥胖病患之用途 | |
| US10166207B2 (en) | Acamprosate formulations, methods of using the same, and combinations comprising the same | |
| AU2006252051B2 (en) | Orodispersible Pharmaceutical Composition for Oromucosal or Sublingual Administration of Agomelatine | |
| CN101132777A (zh) | 用于睡眠障碍的药物组合物 | |
| JP2008524332A5 (ja) | 睡眠障害のための医薬組成物 | |
| CN104168895A (zh) | 包含西地那非作为活性成分的掩蔽苦味的高含量快速溶解膜 | |
| AU2003299723A1 (en) | Compositions and methods for treating upper respiratory congestion | |
| BR112019027286A2 (pt) | formulação de dissolução oral de melatonina com agente acidificante que torna melatonina solúvel em saliva | |
| JP2022506113A5 (https=) | ||
| CN104379138B (zh) | 阿坎酸制剂、其使用方法及包含阿坎酸制剂的组合 | |
| CN101460144A (zh) | AchE-NMDA组合物干胶片 | |
| JP2022548787A (ja) | 治療用製剤およびその使用 | |
| US8748489B2 (en) | Solid pharmaceutical composition containing a combination of an intestinal motility regulating agent and an antiflatulent | |
| TW200534852A (en) | 4-methylpyrazole formulations for inhibiting ethanol intolerance | |
| JP7270958B2 (ja) | 低中毒性抗コリン作動性エステルのための方法および組成物 | |
| CN110650732A (zh) | 锭剂剂型 | |
| CN102600277A (zh) | 一种含有巴戟天提取物的药用组合物 | |
| JP2024523876A5 (https=) | ||
| JP2024511091A5 (https=) | ||
| US20180318228A1 (en) | Method for a slow release of drugs from orally dissolving capsules | |
| CN101198327A (zh) | 治疗半夜失眠的固体组合物和方法 | |
| JP2024531799A5 (https=) |